MEN1 and autoimmune pancreatitis: Current guidelines generally recommend genetic screening only when there is a strong suspicion of a familial link or when there is an association with another endocrine disorder that raises the possibility of a known syndrome, such as MEN1 and AIP-associated syndromes, which are known to predispose to pituitary tumors [19,20].